Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy

Novel therapeutics such as inhibitors of PI3K/Akt/mTOR pathway presents a unique opportunity for the management of diabetic retinopathy (DR). Second generation mTOR inhibitors have the prospect to be efficacious in managing various stages of disease progression in DR. During early stages, the mTOR i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacot, Jorge L., Sherris, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205601/
https://www.ncbi.nlm.nih.gov/pubmed/22132311
http://dx.doi.org/10.1155/2011/589813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205601/
https://www.ncbi.nlm.nih.gov/pubmed/22132311
http://dx.doi.org/10.1155/2011/589813

Ejemplares similares